中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/07/21 | 3,982 | 4,026 | 3,958 | 4,007 | +55 | +1.4% | 1,594,700 |
| 2023/07/20 | 3,961 | 3,969 | 3,932 | 3,952 | -11 | -0.3% | 1,848,500 |
| 2023/07/19 | 3,948 | 3,963 | 3,922 | 3,963 | +55 | +1.4% | 1,775,700 |
| 2023/07/18 | 3,877 | 3,934 | 3,871 | 3,908 | +36 | +0.9% | 1,619,400 |
| 2023/07/14 | 3,849 | 3,923 | 3,843 | 3,872 | +23 | +0.6% | 2,883,000 |
| 2023/07/13 | 3,780 | 3,857 | 3,772 | 3,849 | +73 | +1.9% | 1,664,600 |
| 2023/07/12 | 3,840 | 3,849 | 3,767 | 3,776 | -46 | -1.2% | 2,020,400 |
| 2023/07/11 | 3,851 | 3,895 | 3,822 | 3,822 | -6 | -0.2% | 2,117,100 |
| 2023/07/10 | 3,861 | 3,893 | 3,816 | 3,828 | -79 | -2% | 2,328,700 |
| 2023/07/07 | 3,850 | 3,934 | 3,825 | 3,907 | +26 | +0.7% | 3,384,400 |
| 2023/07/06 | 3,950 | 3,964 | 3,855 | 3,881 | -108 | -2.7% | 3,048,800 |
| 2023/07/05 | 3,969 | 4,002 | 3,959 | 3,989 | -28 | -0.7% | 2,074,500 |
| 2023/07/04 | 4,084 | 4,092 | 3,995 | 4,017 | -107 | -2.6% | 1,964,800 |
| 2023/07/03 | 4,146 | 4,158 | 4,109 | 4,124 | +38 | +0.9% | 1,573,400 |
| 2023/06/30 | 4,128 | 4,132 | 4,047 | 4,086 | -68 | -1.6% | 3,311,000 |
| 2023/06/29 | 4,153 | 4,185 | 4,136 | 4,154 | +4 | +0.1% | 2,277,900 |
| 2023/06/28 | 4,137 | 4,162 | 4,085 | 4,150 | -16 | -0.4% | 4,008,400 |
| 2023/06/27 | 4,175 | 4,220 | 4,124 | 4,166 | -34 | -0.8% | 1,889,900 |
| 2023/06/26 | 4,151 | 4,218 | 4,130 | 4,200 | -21 | -0.5% | 1,969,400 |
| 2023/06/23 | 4,284 | 4,299 | 4,200 | 4,221 | -43 | -1% | 1,876,200 |
| 2023/06/22 | 4,324 | 4,329 | 4,256 | 4,264 | -40 | -0.9% | 1,819,100 |
| 2023/06/21 | 4,315 | 4,352 | 4,270 | 4,304 | +4 | +0.1% | 2,715,700 |
| 2023/06/20 | 4,225 | 4,300 | 4,185 | 4,300 | +63 | +1.5% | 2,346,600 |
| 2023/06/19 | 4,263 | 4,282 | 4,217 | 4,237 | -6 | -0.1% | 2,361,500 |
| 2023/06/16 | 4,150 | 4,249 | 4,127 | 4,243 | +97 | +2.3% | 4,208,800 |
| 2023/06/15 | 4,159 | 4,199 | 4,143 | 4,146 | -16 | -0.4% | 2,856,300 |
| 2023/06/14 | 4,178 | 4,178 | 4,123 | 4,162 | +9 | +0.2% | 2,947,700 |
| 2023/06/13 | 4,084 | 4,155 | 4,057 | 4,153 | +104 | +2.6% | 3,112,400 |
| 2023/06/12 | 4,001 | 4,065 | 3,999 | 4,049 | +84 | +2.1% | 1,926,800 |
| 2023/06/09 | 3,950 | 4,013 | 3,946 | 3,965 | +100 | +2.6% | 4,098,300 |
| 2023/06/08 | 3,921 | 3,951 | 3,839 | 3,865 | -106 | -2.7% | 2,674,400 |
| 2023/06/07 | 4,040 | 4,068 | 3,971 | 3,971 | -89 | -2.2% | 3,647,500 |
| 2023/06/06 | 3,962 | 4,064 | 3,955 | 4,060 | +137 | +3.5% | 3,257,700 |
| 2023/06/05 | 3,915 | 3,923 | 3,873 | 3,923 | +42 | +1.1% | 2,151,000 |
| 2023/06/02 | 3,848 | 3,886 | 3,829 | 3,881 | +69 | +1.8% | 2,291,400 |
| 2023/06/01 | 3,781 | 3,812 | 3,758 | 3,812 | +57 | +1.5% | 1,971,800 |
| 2023/05/31 | 3,764 | 3,791 | 3,737 | 3,755 | -60 | -1.6% | 10,710,800 |
| 2023/05/30 | 3,799 | 3,840 | 3,758 | 3,815 | +9 | +0.2% | 2,774,700 |
| 2023/05/29 | 3,783 | 3,823 | 3,765 | 3,806 | +53 | +1.4% | 3,155,800 |
| 2023/05/26 | 3,753 | 3,757 | 3,725 | 3,753 | -7 | -0.2% | 2,655,000 |
| 2023/05/25 | 3,728 | 3,764 | 3,706 | 3,760 | +8 | +0.2% | 3,052,600 |
| 2023/05/24 | 3,721 | 3,772 | 3,704 | 3,752 | +10 | +0.3% | 2,437,700 |
| 2023/05/23 | 3,734 | 3,758 | 3,692 | 3,742 | +41 | +1.1% | 3,115,700 |
| 2023/05/22 | 3,607 | 3,707 | 3,601 | 3,701 | +94 | +2.6% | 2,801,400 |
| 2023/05/19 | 3,620 | 3,622 | 3,588 | 3,607 | +19 | +0.5% | 1,994,000 |
| 2023/05/18 | 3,594 | 3,613 | 3,585 | 3,588 | -3 | -0.1% | 1,914,700 |
| 2023/05/17 | 3,614 | 3,621 | 3,581 | 3,591 | -37 | -1% | 2,115,100 |
| 2023/05/16 | 3,633 | 3,638 | 3,614 | 3,628 | +15 | +0.4% | 2,051,000 |
| 2023/05/15 | 3,592 | 3,616 | 3,580 | 3,613 | +38 | +1.1% | 1,525,300 |
| 2023/05/12 | 3,558 | 3,589 | 3,548 | 3,575 | +43 | +1.2% | 2,407,600 |
201～
250
件表示中 / 3457件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 505,000円 | -3.7% | +4.1% | 1.62% | 24.77倍 | 5.11倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 552,800円 | +9.3% | -0.9% | 1.09% | 55.77倍 | 6.28倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 416,000円 | +2.0% | +4.2% | 4.71% | 112.52倍 | 0.90倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 655,700円 | +6.0% | +131.3% | 1.83% | 14.24倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 152,500円 | +2.9% | +72.2% | 4.85% | 91.15倍 | 1.71倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
